Publikationen

Cartellieri M, Feldmann A, Koristka S, Arndt C, Loff S, Ehninger A, von Bonin M, Bejestani EP, Ehninger G, Bachmann MP. (2016): Switching CAR T cells on and off: a novel modular platform for retargeting of T cells to AML blasts. Blood Cancer J. 6 (8): e458. doi: 10.1038/bcj.2016.61.

Cartellieri M., Koristka S., Arndt C., Feldmann A., Stamova S., von Bonin M., Topfer K., Kruger T., Geib M., Michalk I., Temme A., Bornhauser M., Lindemann D., Ehninger G. and Bachmann M. (2014): A novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human T cells. PLoS.One. 9: p.e93745, doi: 10.1371/journal.pone.0093745.

Kloss C.C., Condomines M., Cartellieri M., Bachmann M., and Sadelain M. (2013). Combinatorial antigen-recognition with balanced signaling ensures selective tumor eradication by engineered T cells. Nat.Biotechnol. 31: 71-5.

Cartellieri M., Michalk I., von Bonin M., Krüger T., Stamova S., Koistka S., Arndt C., Feldmann A., Schmitz M., Wermke M., Lindemann D., Bornhäuser M., Ehninger G., and Bachmann M. (2012). Chimeric antigen receptor-engineered T cells for immunotherapy of acute myeloid leukemia. Blood (abstract); [118]: 1124-5.

PubMed